Skip to content

Clinical trials

Asperger Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asperger Syndrome Country / region: United States Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20043
20053
20063
20075
20086
20097
20109
20115
20127
20135
20142
20153
20161
20171
20182
20201
20212
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Terminated5
Recruiting4
Active, not recruiting3
Unknown status3
Withdrawn3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of South Florida6
Massachusetts General Hospital4
Yale University4
Boston Children's Hospital3
Forest Laboratories3
Indiana University3
National Institute of Mental Health (NIMH)3
Children's Hospital Medical Center, Cincinnati2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Icahn School of Medicine at Mount Sinai2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asperger Syndrome70
Autistic Disorder59
Autism Spectrum Disorder44
Child Development Disorders, Pervasive31
Attention Deficit Disorder with Hyperactivity7
Obsessive-Compulsive Disorder7
Anxiety Disorders6
Anxiety, Separation5
Generalized Anxiety Disorder5
Phobia, Social5

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.